Clinical Trials Browser

Phase 1 × Neuroendocrine Tumors × pelcitoclax × Clear all

NCT04893759 2025-04-17

A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors

Phase 1 Terminated

Neuroendocrine Tumors